As expected, the vast majority of naïve CD4 (CD4+RA+CCR7+: 99.2 ± 0.4%) and CD8 (CD8+RA+CCR7+: 90.8 ± 2.5%) T lymphocytes were positive for both markers (Fig. 2A). This evidence concerns the gene CD4 and rheumatoid arthritis.